---
$id: https://graph.org.ai/products/commodity/51171811
$type: Product
source: UNSPSC
code: "51171811"
title: "Combinational fructose dextrose and phosphoric acid"
class: "51171800"
classTitle: "Antiemetics and antinauseants and antivertigo agents"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Combinational fructose dextrose and phosphoric acid

**UNSPSC Code**: 51171811
**Class**: [Antiemetics and antinauseants and antivertigo agents](Antiemetics and antinauseants and antivertigo agents.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a combination drug and antiemetic preparation. The first component of this combination drug is a hexose, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6YSS42VSEV. European Medicines Agency schedules Fructose in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13925MIG. Fructose generally arises in the molecular formula C6H12O6. The term 'fructose' is an FDA designation. SMILES: C(C1C(C(C(O1)(CO)O)O)O)O. The second component of this combination drug is a hexose with the molecular formula C6H12O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5SL0G7R0OK, chemically known as sugar, grape but generally known as anhydrous dextrose, which bears US NIH Compound Identifier 5793. European Medicines Agency schedules Glucose in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13981MIG. World Health Organization schedules anhydrous dextrose in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: O1C(C(O)C(O)C(O)C1O)CO. The third component of this combination drug is an acid with the molecular formula H3O4P, chemically known as phosphoric acid, and which bears US NIH Compound Identifier 1004. European Medicines Agency schedules Phosphoric Acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB12212MIG, SUB12213MIG, SUB14854MIG, SUB22394, SUB22400, SUB29997, SUB35788, SUB36455, SUB37010, and SUB42701.

